Hiroaki Wakimoto
- Molecular Biology top 1%
- Oncology top 0.5%
- Genetics top 0.5%
- Genetics top 0.2%
- Cancer Research top 1%
- Co-authors
- Samuel D. RabkinRobert L. MartuzaKhalid ShahDaniel P. CahillWilliam T. CurryMasaru AoyagiDavid N. LouisE. Antonio Chiocca
- Topics
- Virus-based gene therapy research (65 papers)Glioma Diagnosis and Treatment (48 papers)CAR-T cell therapy research (41 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Hiroaki Wakimoto
177 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 4.8k
- Oncology 3.8k
- Genetics 2.9k
- Genetics 2.3k
- Cancer Research 1.5k
Countries citing papers authored by Hiroaki Wakimoto
This map shows the geographic impact of Hiroaki Wakimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Wakimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Wakimoto more than expected).
Fields of papers citing papers by Hiroaki Wakimoto
This network shows the impact of papers produced by Hiroaki Wakimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Wakimoto. The network helps show where Hiroaki Wakimoto may publish in the future.
Co-authorship network of co-authors of Hiroaki Wakimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Wakimoto. A scholar is included among the top collaborators of Hiroaki Wakimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Wakimoto. Hiroaki Wakimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 88 | |
| 3 | 61 | |
| 4 | 46 | |
| 5 | 59 | |
| 6 | 28 | |
| 7 | 31 | |
| 8 | 73 | |
| 9 | 100 | |
| 10 | 119 | |
| 11 | Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitorsbreakdown → | 376 |
| 12 | 130 | |
| 13 | 200 | |
| 14 | 186 | |
| 15 | 70 | |
| 16 | 69 | |
| 17 | 68 | |
| 18 | 26 | |
| 19 | 88 | |
| 20 | 279 |
About Hiroaki Wakimoto
Hiroaki Wakimoto is a scholar working on Genetics, Oncology and Genetics, having authored 185 papers that have together received 9.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (65 papers), Glioma Diagnosis and Treatment (48 papers) and CAR-T cell therapy research (41 papers). The work is most often cited by research in Genetics (2.3k citations), Oncology (3.8k citations) and Genetics (2.9k citations). Hiroaki Wakimoto has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Samuel D. Rabkin, Robert L. Martuza, Khalid Shah, Daniel P. Cahill, William T. Curry, Masaru Aoyagi, David N. Louis, E. Antonio Chiocca, Ryuichi Kanai and Jianfang Ning. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.